ENGLEWOOD, Colo., Jan. 17, 2018 -- Gevo, Inc. (NASDAQ:GEVO), today announced it will be participating in the alphaDIRECT BioEconomy Virtual Conference Series on Thursday, January 18, 2018 at 12:00 PM MST/2:00 PM EST.
Gevo’s Chief Executive Officer, Dr. Patrick Gruber, will present a detailed corporate update, followed by a brief open question and answer session with the investment community. The presentation will be webcast live and made available for replay on the company’s website (www.gevo.com) under the Investors section and on the alphaDIRECT BioEconomy Investor Center page (www.bioeconomyinvestor.com).
Investors interested in attending or participating in the virtual conference series must register using the link below. Please note that registration for the live event is limited to the first 300 registrants and is based on a first come first served basis. Questions will be answered based on the allotted time. A webcast replay will be available following the live event on Gevo’s and the BEI Investor Center’s websites and can be accessed and replayed at any time.
To register, please visit:
https://pgi.webcasts.com/starthere.jsp?ei=1178365&tp_key=85b6c0a4ca
About Gevo
Gevo is a leading renewable technology, chemical products, and next generation biofuels company. Gevo has developed proprietary technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstocks. Gevo’s strategy is to commercialize bio-based alternatives to petroleum-based products to allow for the optimization of fermentation facilities’ assets, with the ultimate goal of maximizing cash flows from the operation of those assets. Gevo produces isobutanol, ethanol and high-value animal feed at its fermentation plant in Luverne, MN. Gevo has also developed technology to produce hydrocarbon products from renewable alcohols. Gevo currently operates a biorefinery in Silsbee, TX, in collaboration with South Hampton Resources Inc., to produce renewable jet fuel, octane, and ingredients for plastics like polyester. Gevo is committed to a sustainable bio-based economy that meets society’s needs for plentiful food and clean air and water. Learn more at our website: www.gevo.com.
About alphaDIRECT BioEconomy Investor
alphaDIRECT BioEconomy Investor (BEI) is a research and Investor Intelligence firm that creates and implements digital content and programs to help investors better understand a company’s key drivers including industry dynamics, technology, strategy, outlook and risks as well as the impact they could have on the stock price. BEI’s expertise encompasses a variety of sectors including Chemicals and Materials, Fuels, Nutrition, AgTech, Raw Materials, Bioconversion and Manufacturing and Genetics and Genomics. BEI was founded by Wall Street veteran and research analyst, Shawn Severson, after seeing a significant shift in the investment industry that resulted in less fundamental research conducted on small cap companies and a significant decline in information available to all investors. BEI’s mission is to bridge that information gap and engage companies and investors in a way that opens information flow and analytical insights.
Investor and Media Contact
Shawn M. Severson
Integra Investor Relations
+1 415-233-7094
[email protected]
www.integra-ir.com


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



